Covered recipient · General Payments record
ROBERT ALLAN HAVARD
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2025
$57,117.18
- Reported across 218 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,315.00 | 11 |
| Food and Beverage | $1,154.61 | 54 |
| Education | $43.25 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $6,488.78 | 12 |
| PFIZER INC. | $2,986.66 | 8 |
| Gilead Sciences, Inc. | $1,311.44 | 7 |
| Incyte Corporation | $878.88 | 2 |
| Geron Corporation | $780.00 | 1 |
| Cardinal Health 110 LLC | $275.00 | 1 |
| Acerta Pharma LLC | $142.53 | 6 |
| Immunocore Limited | $121.31 | 3 |
| GlaxoSmithKline, LLC. | $76.43 | 4 |
| ARRAY BIOPHARMA INC | $56.03 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.18 | 2 |
| Merck Sharp & Dohme Corporation | $38.76 | 2 |
| Exelixis Inc. | $33.61 | 2 |
| Tempus AI, Inc | $30.93 | 1 |
| Astellas Pharma US Inc | $27.26 | 1 |
| EMD Serono, Inc. | $23.83 | 1 |
| Azurity Pharmaceuticals, Inc. | $23.65 | 1 |
| GENZYME CORPORATION | $22.91 | 1 |
| Syndax Pharmaceuticals, Inc. | $21.81 | 1 |
| Celgene Corporation | $20.74 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.59 | 1 |
| Janssen Biotech, Inc. | $19.92 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.56 | 1 |
| ABBVIE INC. | $19.36 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.82 | 1 |
| BeOne Medicines USA, Inc. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (66)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.